Home › NDC Lookup › RxCUI directory › RxCUI 2604794

0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] — RxCUI 2604794

RxNorm drug concept · Semantic branded drug
RxCUI 2604794 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2604794
Official name0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known as0.5 ML Amvuttra 50 MG/ML Prefilled Syringe; amvuttra 25 MG in 0.5 ML Prefilled Syringe; Amvuttra 25 MG per 0.5 ML Prefilled Syringe
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Vutrisiran Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Amvuttra is not a cure, but it's a powerful treatment. You have a condition called transthyretin-mediated amyloidosis, where a protein called TTR misfolds and builds up in your bod...
  • What exactly is Amvuttra treating — is it a cure?
  • Just once every 3 months — that's only four times a year. It's a subcutaneous injection given by a healthcare professional, similar to a flu shot but under the skin rather than int...
  • How often do I need to come in for my injection?
📖 Read our full Vutrisiran Injection guide →

🕸️ Concept Web — How 0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Am... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra] RxCUI 2604794

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Vutrisiran 2604578
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Amvuttra 2604790
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Vutrisiran Prefilled Syringe 2604787
    • Vutrisiran Injectable Product 2604786
    • Vutrisiran Prefilled Syringe [Amvuttra] 2604793
    • Amvuttra Injectable Product 2604792
    • Prefilled Syringe 721656
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Vutrisiran 50 MG/ML [Amvuttra] SBDC · 2604791
  • Vutrisiran Prefilled Syringe [Amvuttra] SBDF · 2604793
  • Amvuttra Injectable Product SBDG · 2604792
  • Amvuttra BN · 2604790

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2604794 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71336-1003-01 1 SYRINGE, GLASS in 1 CARTON (71336-1003-1) / .5 mL in 1 SY... AMVUTTRA Alnylam Pharmaceuticals, Inc. 2022-06-13
Observed labelers: Alnylam Pharmaceuticals, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0225 Inj, vutrisiran, 1 mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.